
Walgreens WellTransitions Program Endorsed for Improving Adherence
The American Hospital Association recognized the program, in which pharmacists work alongside hospital staff, for reducing readmissions through improved medication adherence.
The American Hospital Association recognized the program, in which pharmacists work alongside hospital staff, for reducing readmissions through improved medication adherence.
The American Hospital Association (AHA) announced on September 16, 2013, that it is endorsing the
AHA Solutions, Inc., a subsidiary of AHA, awards its endorsement to products and services that effectively support hospitals and health care organizations. After a careful selection process, the WellTransitions program was chosen for its efforts to reduce the rate of avoidable readmissions, a top concern for many hospitals.
To reduce readmission rates and overall health care costs, WellTransitions, launched last year,
The program has already been shown to help reduce readmission rates. Walgreens announced that early results indicate that within the first 6 months that WellTransitions was operational in 5 hospitals, the unadjusted 30-day readmission rate for patients in the program was 9.4%, compared with 14.3% for patients not participating in the program.
“The Walgreens WellTransitions program will serve as another tool for hospitals seeking to reduce readmissions and support overall community wellness,” said Anthony J. Burke, president and CEO of AHA Solutions in a
So far, WellTransitions has been implemented in more than 15 hospitals and is set to be expanded to a number of other hospitals throughout the country as well. Walgreens plans to conduct a formal research study to better evaluate the program’s effect on hospital readmission rates.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.